Introduction
Monobacteria is a common fungus that causes skin, mucous membrane and deep tissue infections, especially among people with low immunity. The correct use of antibiotics, a key drug for the treatment of pyromococcal infections, in primary health-care institutions is critical to improving efficacy and reducing drug resistance.
II. Mechanisms for the functioning of antibiotics:
Acetylene-type drugs interfere with the synthesis of fungal membrane rhesus steroids by inhibiting fungal cell pigment P450, relying on wool thallium 14α-demethylases, causing damage to the membrane structure and function, causing a material leak within fungal cells and ultimately inhibiting fungal growth and reproduction. This mechanism of action is selective and has a greater impact on fungal cells and a relatively low toxicity to human cells, which is one of the bases of its extensive clinical application.
III. Description of common antibiotics:
1. Fluorinated hysteres: with oral and intravenous preparations, high bioavailability, good tissue penetration, and wide distribution among tissues and body fluids, including brain vertebrates. Its antibacterial spectrum is relatively narrow, with a high level of antibacterial activity and a relatively low degree of tolerance and adverse response to common pyrococcus infections, such as white pyrococcus, and is one of the most common drugs used in primary medical institutions to treat pyromococcal infections, oral pyrococcusemia and amphicemia in patients with reduced non-neutral particle cells.
2. Ictarconium: oral capsules, oral fluids and intravenous preparations. The antibacterial spectroscopy is wider than fluorine and, in addition to being effective for common pyroclastics, there is some antibacterium activity for some non-white pyroclastics, such as halophthalmosis and kroumyl. The drug metabolic characteristics make it more concentrated in tissues such as skin, nails, which are applied to skin mucous membrane infections, as well as to shallow fungi infections and decks, but the absorption of oral formulations is more influenced by food and stomach acids and requires attention when used.
IV. Proper use of methods:
1. Diagnosis is clear: Before the use of americium antibiotics, the diagnosis of pyrocococcal infections, such as microscope examinations, fungi culture and pharmacological sensitivity tests, should be carried out through a fungal examination whenever possible. This helps to identify pathogen strains, to guide the use of precision drugs and to avoid unnecessary drug use and drug resistance. For example, for patients suspected of pyromococcal vaginal infections, vaginal genus smears and culture should be performed to determine if the pyroccus infection and specific strains are to be treated with a decision on whether or not to use the acetate drug.
2. Drug selection: The choice of appropriate acetate drugs is based on the area of infection, its severity and the individual circumstances of the patient. In the case of mild skin mucous mellitus infections, such as oral membranes, priority is given to local medicines, such as enzyme-based enzymes or icconium mouth stickers, while oral fluoroconcertazine is often more effective, while in the case of deep dysentery infections or systematic pyrophilosophylosis, such as haemophilusemia, the use of e.g. fluoroconcertazone or Ecracontium may be necessary for intravenous use and the dose and treatment process should be adjusted as appropriate and, if necessary, the combination of medication or referral to a higher hospital for further treatment.
3. Dosages and treatments: Medicines are given strictly in accordance with the doses and treatments recommended in the medical instructions and clinical guidelines. For example, the treatment of pyromococcal vaginitis is generally administered at a single dose of 150 mg, whereas for pyromocemia, the first dose may be 800 mg, followed by 400 mg per day, usually for approximately two weeks, depending on the patient ‘ s clinical response and fungi review. The shock therapy is a monthly one-week, two times a day, 200 mg for three to four months in a row to ensure that the drug reaches an effective therapeutic concentration on deck and is completely eliminated from fungi to prevent recurrence.
4. Monitoring and adjustment: In the course of treatment, there is a need to monitor closely the improvement of the patient ‘ s symptoms, the adverse effects of drugs and changes in fungal indicators. In the case of adverse reactions, such as nausea, vomiting, liver abnormalities, etc., after a patient uses a herbal drug, the severity of the adverse reaction should be assessed in a timely manner and consideration should be given to adjusting the dose of the drug or to replacing the treatment programme; the fungus culture should be reviewed on a regular basis and, if it is found to be persistent or resistant, the drug used should be adjusted in a timely manner, and other antifluent drugs or combinations of drugs, such as a combination of abacterium and americ acid drugs, may be selected for treatment of incurable tremor infections.
V. Preventing drug resistance:
1. Reasonable use of medicines: avoiding overuse and unregulated use of americium antibiotics, strict control of drug indicators and prevention of abuse. For example, the preventive use of americium is generally not recommended for non-asymptomosis patients, and careful use of short-range preventive drugs, after weighing the pros and cons, is considered only when high-risk factors exist and the risk of infection is expected.
2. Infection control measures: Increased prevention and control of infection in primary health-care facilities, such as strict enforcement of hygiene and hygiene regulations, a system of sterilization, and prevention of the transmission and cross-infection of pyromoccal in hospitals. For patients with intrusive operations such as holding catheters for urine, central veins, etc., the catheter care should be strengthened, the catheters should be replaced on a regular basis, the retention of catheters should be kept as short as possible, and the risk of dysentery infection should be reduced, thus reducing the demand for acetylene-type drugs and indirectly preventing drug resistance.
Primary health care institutions, when using antibiotics for the treatment of pyromococcal infections, should be fully aware of the mechanisms, characteristics, correct methods of use and drug-resistant preventive measures of drugs, by regulating clinical behaviour, improving the effectiveness of the treatment of pyromococcal infections, ensuring the safety of the patients and contributing to the rational use of anti-fashion drugs and curbing drug-resistant bacteria, thus raising the level of primary health care services and better serving the general population.
